Worldwide, we have witnessed an expansion of robot-assisted laparoscopic surgery (RALS) and thanks to the global adoption of high-resolution diagnostic imaging technologies, an increased incidence of newly diagnosed prostatic, renal and bladder cancers has been recorded with concurrent second primary urological cancer diagnoses increasing by 1.
5%. Diverse authors have reported their findings concerning synchronous multi-visceral malignances robotic treatment within the scientific literature. The aim of this study is to comprehensively review all reported articles describing concurrent upper and lower RALS using a singular robotic port scheme within the same intervention for renal malignances and concomitant prostatic or bladder cancers. To the best of our knowledge and vigorous literature search, this is the first study that comprehensively evaluates and reports all combined upper and lower urinary tract surgeries published so far. In carefully selected patients, thanks to multidisciplinary preoperative assessment and surgical planning a combined robotic approach can reduce the morbidity, complications, hospital admissions and the overall length of hospitalization.
Journal of robotic surgery. 2021 Nov 08 [Epub ahead of print]
Simone Scarcella, Daniele Castellani, Pietro Piazza, Carlo Giulioni, Luca Sarchi, Marco Amato, Carlo Andrea Bravi, Maria Peraire Lores, Rui Farinha, Sophie Knipper, Erika Palagonia, Sérgio Augusto Skrobot, Dries Develtere, Camille Berquin, Céline Sinatti, Hannah Van Puyvelde, Ruben De Groote, Paolo Umari, Geert De Naeyer, Lucio Dell'Atti, Giulio Milanese, Stefano Puliatti, Jeremy Yuen-Chun Teoh, Andrea B Galosi, Alexandre Mottrie
Department of Urology, Polytechnic University of Marche Region, Umberto I Hospital "Ospedali Riuniti", 71 Conca Street, 60126, Ancona, Italy. ., Department of Urology, Polytechnic University of Marche Region, Umberto I Hospital "Ospedali Riuniti", 71 Conca Street, 60126, Ancona, Italy., Division of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Urology Department, University of Modena and Reggio Emilia, Modena, Italy., Department of Urology, Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium., Department of Urology, Son Espases University Hospital, Palma de Mallorca, Spain., ORSI Academy, Melle, Belgium., Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Hospital Santa Catarina de Blumenau, Blumenau, Brazil., Division of Surgery and Interventional Sciences, University College London, London, UK., S.H.Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
PubMed http://www.ncbi.nlm.nih.gov/pubmed/34748165